Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda

Failure on second-line antiretroviral therapy (ART) with protease inhibitor (PI) mutations (VF-M) is on the rise. However, there is a paucity of information on the factors associated with this observation in low-income countries. Knowledge of underlying factors is critical if we are to minimize the number of PLHIV switched to costly third-line ART. Our study investigated the factors associated with VF-M.

18

17+

https://doi.org/10.1186/s12981-021-00338-y